ZOMEDICA CORP (ZOM)

CA98980M1095 - Common Stock

0.1459  +0 (+1.32%)

After market: 0.1461 +0 (+0.14%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ZOMEDICA CORP

NYSEARCA:ZOM (3/28/2024, 8:00:00 PM)

After market: 0.1461 +0 (+0.14%)

0.1459

+0 (+1.32%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap138.60M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ZOM Daily chart

Company Profile

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company is headquartered in Ann Arbor, Michigan and currently employs 85 full-time employees. The company went IPO on 2013-10-28. The firm is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The firm's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF).

Company Info

ZOMEDICA CORP

100 Phoenix Drive, Suite 125

Ann Arbor MICHIGAN 48108

P: 17343692555

CEO: Robert Cohen

Employees: 85

Website: https://zomedica.com/

ZOM News

News Image2 months ago - InvestorPlace3 High-Reward Penny Stocks to Uncover Big Gains

Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions.

News Image2 months ago - InvestorPlace7 Penny Stocks to Buy on the Dip: February 2024

With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks.

News Image2 months ago - InvestorPlace3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth

Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future.

News Image2 months ago - Seeking AlphaZomedica says Q4 revenue is expected to be over $7M (NYSE:ZOM)

Zomedica expects strong revenue growth in 2023, with Q4 revenue projected to be over $7 million and total 2023 revenue expected to exceed $25 million.

News Image2 months ago - InvestorPlace3 Breakout Penny Stocks Primed for Massive Gains

Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors.

News Image3 months ago - InvestorPlaceBudget Bets: Top 3 Penny Stocks with Potential for Explosive Growth

These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs.

ZOM Twits

Here you can normally see the latest stock twits on ZOM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example